Scottish biotech firm, Cytomos, raises £4 million funding led by Archangels to advance cell analysis solutions for the biopharma industry, aiming to fast-track novel therapies to market

Scottish-based biotech firm Cytomos has raised a funding round of £4 million which was led by existing investors Archangels and includes participation from Old College Capital, Scottish Enterprise and new investor British Business Bank.

Cytomos has developed an advanced cell analysis solution for the biopharma industry. ‘Through its CDS platform, Cytomos empowers biopharma to bring novel therapies to market faster and radically reduce costs by enabling critical decision-making much earlier’. Funds will further the development of its technology and support the expansion of its team.

Want to see Scotland under the SNP?

Sign up to receive our weekly newsletter and join the fightback against Scottish Nationalism.